{"slideshow_credits": null, "snippet": "The Federal Trade Commission said on Monday that it would require Johnson & Johnson to sell its system for surgically treating serious wrist fractures as a condition of approval for the company's proposed $21.3 billion acquisition of Synthes.", "abstract": "The Federal Trade Commission said on Monday that it would require Johnson & Johnson to sell its system for surgically treating serious wrist fractures as a condition of approval for the company's proposed $21.3 billion acquisition of Synthes.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Dealbook", "role": "reported", "rank": 1, "organization": ""}], "original": "By DEALBOOK"}, "web_url": "http://dealbook.nytimes.com/2012/06/11/j-j-cleared-for-synthes-acquisition/", "lead_paragraph": null, "headline": {"main": "J.&J. Cleared for Synthes Acquisition", "kicker": "DealBook"}, "_id": "4fdf29d932439115e30b7156", "word_count": "57", "multimedia": [], "pub_date": "2012-06-11T17:36:23Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "organizations", "value": "Biomet Incorporated", "rank": "1"}, {"name": "organizations", "value": "Federal Trade Commission", "rank": "2"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": "3"}, {"name": "organizations", "value": "Synthes Inc", "rank": "4"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}